Dapagliflozin Impurity-1

Dapagliflozin Impurity-1 represents a highly specialized and sought-after analytical standard, meticulously crafted for precise pharmaceutical impurity profiling and quantitative method validation in modern laboratories. This compound, chemically recognized as 1-Chloro-2-(4-ethoxybenzyl)-4-iodobenzene, is manufactured under the rigorous quality management systems of Manasa Life Sciences to support complex drug development lifecycles. It is documented under CAS number 1103738-29-9 and is characterized by a molecular formula of C₁₅H₁₄ClIO along with a molecular weight of 372.63 g/mol. Our technical team utilizes state-of-the-art analytical techniques, including HPLC, LC-MS, NMR, and IR spectroscopy, to confirm the structural integrity and high purity of every unit produced. By integrating a certified COA and MSDS into our supply process, we provide the essential data that pharmaceutical manufacturers require to maintain continuous alignment with ICH guidelines, thereby streamlining their internal validation processes and facilitating smooth global regulatory filings across USP, EP, USFDA, and EMA jurisdictions.